Login
QUANTRX BIOMEDICAL CORP logo

QUANTRX BIOMEDICAL CORP

QuantRx Biomedical Corp. engages in developing and commercializing its patented miniform pads (PADs) and PAD based over-the-counter products for the treatment of hemorrhoids, minor vaginal infection, urinary incontinence, general catamenial uses, and other medical needs. The company is headquartered in Tualatin, Oregon. The firm is also developing genomic diagnostics for the laboratory market, based on its lateral flow patents (the Diagnostics Business). The firm's platforms include inSync, Unique and original equipment manufacturer (OEM) branded over-the-counter and laboratory testing products based on its core intellectual property related to the Company PAD technology. Its OTC Business includes commercialization of its InSync feminine hygienic interlabial pad, the Unique Miniform for hemorrhoid application, and other treated miniforms, as well as maintaining established and continuing licensing relationships related to the OTC Business. The company also owns certain diagnostic testing technology that is based on its lateral flow patents.

Financial snapshot data is not available right now.

Stock Price

Loading...
Market Cap: $118.04 Thousand

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support